Authors: D Morrone, S Kroep, F Ricci, G Renda, G Patti, P Kirchhof, L Chuang, B van Hout, R De Caterina Published: Journal of clinical medicine, 2020 View publication Background and objectives...
Authors: G L Di Tanna, M Urbich, H S Wirtz, B Potrata, M Heisen, C Bennison, J Brazier, G Globe Published: PharmacoEconomics, 2020 View publication Background and objectives New treatments and interventions...
Authors: M Urbich, G Globe, K Pantiri, M Heisen, C Bennison, H S Wirtz, G L Di Tanna Published: PharmacoEconomics, 2020 View publication Background Heart failure presents a growing clinical and economic...
Authors: S Bangalore, R Shah, X Gao, E Pappadopulos, C G Deshpande, A Shelbaya, R Prieto, J Stephens, R Chambers, P Schepman, R S McIntyre Published: Journal of Medical Economics, 2019 View...
Authors: J A Spoorendonk, M Krol, C Alleman Published: The Journal of Cardiovascular Surgery, 2019 View publication Introduction Peripheral arterial disease (PAD) can lead to severe cases of critical limb ischemia (CLI),...
Authors: S Bangalore, R Shah, E Pappadopulos, C G Deshpande, A Shelbaya, R Prieto, J Stephens, R S McIntyre Published: European Health Journal Quality of Care and Clinical Outcomes, 2018 View publication...
Authors: H E Heemstra, R Nieuwlaat, M Meijboom, H J Crijns Published: Netherlands Heart Journal, 2011 View publication Background Atrial fibrillation (AF) is the most common sustained atrial arrhythmia and it is...
Authors: A D Joshi, J A Carter, M F Botteman, S Kaura Published: Clinical Therapeutics, 2011 View publication Background Zoledronic acid (ZOL) significantly reduces the risk of new skeletal-related events (SREs) in...
Authors: J A Carter, A Joshi, S Kaura, M F Botteman Published: Journal of Medical Economics, 2011 View publication Objective Cost effectiveness of zoledronic acid in the management of skeletal metastases in...